Our client’s new product needed forecast-ready market shares
Our client had acquired a new product. They had very limited market research to predict market shares for their forecast. Their budget wouldn’t stretch to primary research. They were also facing very short timelines.
So, they chose our MetaConjoint® platform, which gave them:
1
Peak market shares for seven markets in half the time of primary market research.
MetaConjoint delivered robust peak market share forecasts for seven countries in half the time needed for primary research. MetaConjoint harnesses the power of more than 80 000 past conjoint responses and so involves no primary research. It is proven to predict shares as well as conjoint surveys.
Value driver insights into a potentially game-changing new endpoint.
The product had a new endpoint which was believed to be a significant value driver. We used published studies and our modeling expertise to determine how performance on that endpoint would drive share.
2
3
A forecast simulator let the client explore areas of uncertainty and update assumptions as more data arrived.
The competitive landscape was volatile:
- There was only one competitor on the market, and it was facing imminent withdrawal.
- Another competitor was likely to launch, but there was uncertainty about whether they would receive accelerated approval.
To help the client see how these events, as well as product profile and competitor changes, would impact product shares, we gave them a forecast simulator.
Result
Our client had a clear understanding of their market share potential and value drivers. Not only that, but they now have an adaptive tool to handle shifts like treatment withdrawal and competitor launches.
We tailor our services to your exact requirements
Get in touch with us and arrange a meeting